Evaluation of Immune Function in Biliary Atresia Children With Prolonged Jaundice
Impaired T-Lymphocyte Proliferative Function in Biliary Atresia Children With Prolonged Jaundice
1 other identifier
observational
30
1 country
1
Brief Summary
Null hypothesis of this study: Biliary atresia patients with cholestatic jaundice do not have systemic immunity defect.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2004
CompletedFirst Submitted
Initial submission to the registry
September 9, 2005
CompletedFirst Posted
Study publicly available on registry
September 12, 2005
CompletedSeptember 12, 2005
June 1, 2005
September 9, 2005
September 9, 2005
Conditions
Eligibility Criteria
You may qualify if:
- Biliary patients older than 1-year-old status post Kasai operation.
You may not qualify if:
- Received liver transplantation, immunosuppresant, systemic immunoglobulin (within 6 months) and obvious infectious episode (within 2 weeks).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Pediatrics, National Taiwan University Hospital
Taipei, 100, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Mei-Hwei Chang, MD
Department of Pediatrics, Natonal Taiwan University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- DEFINED POPULATION
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 9, 2005
First Posted
September 12, 2005
Study Start
April 1, 2004
Last Updated
September 12, 2005
Record last verified: 2005-06